Catalyst Wire Dossier Catalyst Wire Dossier

AZD5148 monoclonal antibody

AZD5148 · AstraZeneca
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AZD5148 monoclonal antibody, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody [Phase 2]

See pricing